Search
Clinical Trials
A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progr
STATUS: Active, Recruiting
A phase III multicenter, randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with ocrelizumab in adult patients with PPMS
STATUS: Active, Recruiting
ARTIOS
STATUS: Completed
M18
STATUS: Completed
M14
STATUS: Completed
Publications
Featured Investigator
Xiaowei (Sherry) Yan
PhD, MS
Dr. Yan is a data scientist and biostatistician. She specializes in methodology development and the application of advanced analytics using EHR.